Aiman J Faruqi

6PUBLICATIONS
58CO-AUTHORS
Carbon capture engineering (excl. sequestration)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2024
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Ann Y Park, Michael Leney-Greene, Matthew Lynberg

|Jan 03, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Ann Y Park, Michael Leney-Greene, Matthew Lynberg

|Nov 18, 2022
Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy.

Akansha Jalota, Courtney E Hershberger, Manishkumar S Patel

|Aug 08, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.

Aiman J Faruqi, John A Ligon, Paul Borgman

|Jul 11, 2020
HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.

Sarah A Cook, William A Comrie, M Cecilia Poli

Pageof 1